D. Heal

发表

Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release

IC Kilpatrick, M. Traut, D. Heal, 2001, International Journal of Obesity.

Thermogenic effects of sibutramine and its metabolites

M. Stock, D. Heal, M. Stock, 1999, British journal of pharmacology.

Modulation of sibutramine‐induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by α2‐adrenoceptors

D. Heal, S. Stanford, K. Wortley, 1999, British journal of pharmacology.

Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine

M. Stock, D. Heal, Y.-L. Liu, 2002, International Journal of Obesity.

Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β1 but Not β2‐Adrenoceptors in Rat Cortex

D. Heal, W. R. Buckett, S. Butler, 1989 .

Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine

S. Aspley, B. Lancashire, M. Prow, 2001, International Journal of Obesity.

Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d‐amphetamine: modulation by α2‐adrenoceptors

S. Stanford, D. Heal, K. Wortley, 1999, British journal of pharmacology.

Measurement of 3‐methoxy‐4‐hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic α2‐adrenoceptor function

D. Heal, W. R. Buckett, M. Prow, 1989, British journal of pharmacology.

The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats

M. Bloomfield, M. Youdim, D. Grahame-Smith, 1980, Neuropharmacology.

Development of antidepressant drugs for the 1990s: Progress or procrastination?

D. Heal, W. R. Buckett, D. Heal, 1991 .

5‐Hydroxytryptamine‐Stimulated Inositol Phospholipid Hydrolysis in the Mouse Cortex Has Pharmacological Characteristics Compatible with Mediation via 5‐HT2 Receptors but This Response Does Not Reflect Altered 5‐HT2 Function After 5,7‐Dihydroxytryptamine Lesioning or Repeated Antidepressant Treatment

S. McClue, D. Heal, P. Godfrey, 1988, Journal of neurochemistry.

Evidence that RU 24969‐induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5‐HT1B receptor

S. Cheetham, D. Heal, 1993, British journal of pharmacology.

Determination of the role of noradrenergic and 5‐hydroxytryptaminergic neurones in postsynaptic α2‐adrenoceptor desensitization by desipramine and ECS

D. Heal, W. R. Buckett, M. Prow, 1991, British journal of pharmacology.

A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents

S. Cheetham, D. Heal, K. Martin, 1998, British journal of pharmacology.

β‐ADRENOCEPTOR AGONISTS ENHANCE 5‐HYDROXYTRYPTAMINE‐MEDIATED BEHAVIOURAL RESPONSES

P. Cowen, A. R. Green, D. Heal, 1982, British journal of pharmacology.

Comparison of the effects of sibutramine and other weight‐modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

I. Kilpatrick, D. Heal, H. Rowley, 2000, Synapse.

Determination of 3‐Methoxytyramine in Rat Brain by HPLC with Electrochemical Detection and Its Correlation with Dopamine Function After Administration of a Monoamine Oxidase Inhibitor and L‐3,4‐Dihydroxyphenylalanine

C. L. Davies, D. Heal, C. L. Davies, 1986, Journal of neurochemistry.

The effects of acute and chronic lithium treatment on pilocarpine‐stimulated phosphoinositide hydrolysis in mouse brain in vivo

D. Kendall, D. Heal, P. Whitworth, 1990, British journal of pharmacology.

Sex‐related differences in central adrenergic function and responsiveness to repeated administration of desipramine or electroconvulsive shock

J. Elliott, D. Heal, E. Hurst, 1989, British journal of pharmacology.